KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Payables: 2009-2025

Historic Payables for Thermo Fisher Scientific (TMO) over the last 16 years, with Sep 2025 value amounting to $3.1 billion.

  • Thermo Fisher Scientific's Payables rose 19.72% to $3.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $12.2 billion, marking a year-over-year increase of 15.58%. This contributed to the annual value of $3.1 billion for FY2024, which is 7.21% up from last year.
  • Latest data reveals that Thermo Fisher Scientific reported Payables of $3.1 billion as of Q3 2025, which was up 4.70% from $3.0 billion recorded in Q2 2025.
  • Thermo Fisher Scientific's 5-year Payables high stood at $3.4 billion for Q4 2022, and its period low was $2.1 billion during Q3 2021.
  • Its 3-year average for Payables is $2.8 billion, with a median of $2.8 billion in 2023.
  • Its Payables has fluctuated over the past 5 years, first soared by 51.48% in 2021, then dropped by 15.05% in 2023.
  • Quarterly analysis of 5 years shows Thermo Fisher Scientific's Payables stood at $2.9 billion in 2021, then rose by 17.93% to $3.4 billion in 2022, then dropped by 15.05% to $2.9 billion in 2023, then rose by 7.21% to $3.1 billion in 2024, then increased by 19.72% to $3.1 billion in 2025.
  • Its Payables was $3.1 billion in Q3 2025, compared to $3.0 billion in Q2 2025 and $3.0 billion in Q1 2025.